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Abstract
Background: Accumulating evidence suggest that the enteric nervous system (ENS) plays important roles in
gastrointestinal inflammatory responses, which could be in part mediated by Toll-like receptor (TLR) activation.
The aim of this study was to characterise the expression and functionality of TLR2/4/9 in the ENS.
Methods: TLR2/4/9 expression was assessed in the plexuses of adult rats and embryonic ENS cultures by
immunofluorescence and quantitative PCR. Following stimulation with TLR2/4/9 ligands or their combinations,
activation of NF-kB, production of TNF-α, IL-6 and MCP-1 and chemoattraction of RAW264.7 macrophages were
evaluated by means of Western blot, ELISA, immunofluorescence and migration assays in transwell inserts.
Results: TLR2/4/9 staining colocalised with enteric neuronal markers, whereas their presence in enteroglial
processes was low to inexistent. Stimulation of ENS cultures with selective ligands induced NF-kB activation
and release of cytokines and chemokines by neurons and resident immunocytes. TLR2 neutralisation before
lipopolysaccharide (LPS) challenge reduced production of inflammatory mediators, whereas combination of TLR2/4
ligands promoted macrophage migration. Combined stimulation of cultures with LPS and the CpG oligonucleotide
1826 (TLR4/9 ligands) caused a synergic increase in chemoattraction and cytokine production.
Conclusions: Our results suggest that the ENS, and particularly enteric neurons, can integrate a variety of microbial
signals and respond in a relatively selective fashion, depending on the particular TLRs stimulated. These findings
additionally suggest that the ENS is capable of initiating a defensive response against pathogens and expanding
inflammation.
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Background
The enteric nervous system (ENS) is the largest
component of the peripheral nervous system and is
constituted by two cell types, neurons and enteric
glial cells (EGC). It is organized in two major gang-
lionated plexuses, namely the Meissner’s submucosal
(SMP) and the Auerbach’s myenteric (LMMP) ple-
xuses, which control gastrointestinal motility, secre-
tion and blood flow, participate in maintenance of the
epithelial barrier and modulate various processes of
the local immune response [1, 2]. Although a number
of studies have demonstrated that the ENS undergoes
structural and phenotypic plastic changes during
inflammatory responses [3], growing evidence suggests
that it is not only a bystander, but an active player
during inflammation. Indeed, both enteric neurons
and EGCs have been shown to contribute to the
resulting inflammatory phenotype following chemically
induced colitis [4, 5], probably through the release of
several immune mediators [6–9]. Moreover, perineural
inflammation is dense in biopsies from inflammatory
bowel disease patients and is correlated to major
histocompatibility complex class II expression in
EGCs [10], further illustrating the neuroimmune
interactions existing in the intestine.* Correspondence: ester.fernandez@uab.cat1Department of Cell Biology, Physiology and Immunology, Universitat
Autònoma de Barcelona, Bellaterra, Barcelona 08193, Spain
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Toll-like receptors (TLR) are transmembrane receptors
that recognise different highly conserved microorganism-
associated molecular patterns (MAMP), as well as other
molecules such as damage-associated molecular patterns
[11, 12]. Upon MAMP binding, the cytoplasmic domain
recruits different adapter proteins to trigger a variety of
signalling pathways that ultimately activate transcription
factors such as nuclear factor-kB (NF-kB), activating
protein-1 and interferon regulatory factors, which in turn
promote the production of pro-inflammatory cytokines
[13, 14]. TLRs are expressed in most human tissues
including the gastrointestinal tract [15], where they have
been proposed to mediate the cross-talk between host
cells and commensal microflora due to the key role they
play in the innate immune response and in shaping adap-
tive immunity [16, 17].
In recent years, expression of some TLRs in the
ENS has been described [18, 19], and their roles in
intestinal motility, apoptosis and normal development
have progressively been unravelled [19, 20]. In
addition, their immune functions have been also
addressed by some authors [7, 21], but there are still
several questions to be answered, such as whether dif-
ferential recognition of MAMPs by the ENS translates
into microbial-selective responses, or whether TLR-
mediated signalling is involved in expansion of the
inflammatory response. In this context, we aimed to
characterise expression and functionality of TLR2/4/9
in the ENS, focusing on their responses in terms of
cytokine, chemokine and chemoattraction induction
after single or combined ligand challenges. Our re-
sults show that neurons are the main TLR-expressing
cells in enteric plexuses and integrate TLR signals
promoting diverse responses depending on the stimu-
lus received, bringing some new evidence regarding
their roles in defence against pathogens and inflam-
mation enhancement.
Methods
Reagents and antibodies
All culture media, foetal bovine serum, antibiotics, N-2
supplement and 4′,6-diamidino-2-phenylindole (DAPI)
were from Life Technologies (El Prat de Llobregat,
Spain). Trypsin, DNase I, gelatin and Bay 11-7082 were
from Sigma (Madrid, Spain). The synthetic diacylated
lipopeptide Pam2CSK4, a TLR2/6-specific agonist, was
purchased from InvivoGen (San Diego, USA). Lipopoly-
saccharide (LPS) stimulation of TLR4 was performed
with a mixture 1:1 of LPS from Escherichia coli O55:B5
and Salmonella typhosa, both purchased from Sigma.
Phosphorothioate-modified class B CpG oligonucleotides
(ODN) 1826 5′-TCCATGACGTTCCTGACGTT-3′ and
1826 control (cODN) 5′-TCCATGAGCTTCCTGAG
CTT-3′ synthesised by Tib-Molbiol (Berlin, Germany)
were used to stimulate TLR9. Primary antibodies used in
immunofluorescence were rabbit monoclonal anti-TLR2
(1:500; Abcam, Cambridge, UK), rabbit polyclonal anti-
TLR4 (1:100; Novus Biologicals, Cambridge, UK), mouse
monoclonal anti-TLR9 (1:100; Novus Biologicals), chicken
polyclonal anti-GFAP (1:500; Antibodies-online, Aachen,
Germany), mouse monoclonal anti- S100β (1:1000;
Abcam), mouse monoclonal anti-HuC/D (1:200; Life
Technologies), chicken polyclonal anti-β-tubulin III
(1:500; Abcam), rabbit monoclonal anti-NF-kB p65
(1:50; Cell Signaling Technology, Danvers, USA), goat
polyclonal anti-IL-6 (1:250; Santa Cruz Biotechnology),
mouse monoclonal anti-MCP-1 (1:100; Novus Biologicals)
and rabbit polyclonal anti- ionized calcium-binding
adapter molecule (IBA)-1 (1:500; Wako Chemicals). Sec-
ondary antibodies used were Alexa Fluor 488 and 568
donkey and goat anti-rabbit IgG, respectively; Alexa Fluor
568 goat anti-mouse IgG and Alexa Fluor 647 donkey
anti-mouse IgG (1:500; all from Life Technologies),
CF488A donkey anti-chicken IgY (1:2000) and CF488A
donkey anti-mouse IgG (1:500; both from Biotium, Hay-
ward, USA). For Western blotting, rabbit monoclonal
anti-phospho-IkBα (1:1000; Cell Signaling Technol-
ogy), mouse monoclonal anti-β-actin (1:5000; Sigma),
horseradish peroxidase (HRP)-linked goat anti-rabbit
IgG (1:10,000; Cell Signaling Technology) and HRP-
linked sheep anti-mouse IgG (1:100,000; GE Health-
care, Barcelona, Spain) antibodies were used. TLR2
neutralisation was performed with a mouse monoclo-
nal anti-TLR2 antibody (clone T2.5, 10 μg/mL; Novus
Biologicals).
Animals
For ex vivo experiments, 10-week-old male Sprague-
Dawley rats were purchased from Charles River (Les
Oncins, France) and housed in specific pathogen-free
conditions, under a controlled temperature (20 ± 2 °C)
and photoperiod (12 h/12 h light-dark cycle), with
free access to food and water. Animals were euthanized
by CO2 inhalation and distal ileum was removed and
placed in ice-cold oxygenated Krebs solution for sub-
sequent manipulation. Colons were flushed with Krebs
solution, opened along the mesenteric border, pinned flat
in a dissection dish and fixed in Lana’s fixative (4 %
paraformaldehyde, 14 % picric acid in 0.4 M phosphate
buffer).
For in vitro experiments, pregnant Sprague-Dawley
rats purchased from Charles River were killed by CO2
inhalation followed by cardiac puncture exsanguination.
Pregnant uteri were removed and kept in ice-cold
phosphate-buffered saline (PBS) for further dissection.
All animal procedures performed were approved by
the Ethical Committee of the Universitat Autònoma de
Barcelona (code 2669).
Burgueño et al. Journal of Neuroinflammation  (2016) 13:187 Page 2 of 15
Cell cultures
Isolation and culture of rat embryonic ENS was per-
formed as described elsewhere [22]. Briefly, intestines of
rat embryos (E16) were removed and finely diced in
PBS. Tissue fragments were digested with trypsin and
DNase I, and cells obtained were counted and seeded at
a density of 2.4 × 105 cells/cm2 on 24- or 48-well plates,
previously coated with a 0.5 % gelatin solution in sterile
PBS. Stimulation was performed for 24 h after 15-day
culture in serum-free medium (DMEM-F12 (1:1)) con-
taining 1 % of N-2 supplement.
The murine macrophage cell line RAW 264.7 (ATCC®
TIB-71) was purchased from the American Type Culture
Collection and cultured in DMEM supplemented with
10 % heat-inactivated foetal calf serum.
Stimulation experiments were performed for 24 h with
either 100 ng/mL Pam2CSK4, 100 ng/mL LPS, 1 μM
ODN 1826, 1 μM cODN 1826 or combinations of these
ligands. For NF-kB inhibition and TLR2 neutralisation
experiments, cultures were pre-treated for 1 h with
15 μM Bay 11-7082 or 10 μg/mL anti-TLR2 antibody
before MAMP stimulation.
In costimulation experiments, comparison between
expected additive effects and measured effects of TLR
ligand combinations was calculated according to the
model of functional interaction, represented by the
following equation as described in [23]: E(ODN + LPS)
expected = E(ODN)measured + E(LPS)measured –
E(ODN)measured * E(LPS)measured.
Immunofluorescence
Fixed colon was dissected under a stereo microscope
to obtain whole-mount preparations of the SMP and
the LMMP. Adult tissues, as well as ENS cultures
grown on cover-slips, were blocked for 1 h in PBS
containing 4 % horse serum, 0.1 % Triton X-100 and
0.01 % NaN3. Samples were incubated overnight at
4 °C with combinations of TLR2, TLR4 or TLR9 with
Hu C/D, β-tubulin III (neuronal markers), GFAP, S100β
(glial markers), IL-6, MCP-1 or IBA-1 antibodies. Second-
ary antibodies to rabbit, mouse or goat IgG and chicken
IgY were used to detect bound primary antibodies. All
samples were mounted in Vectashield aqueous anti-fading
mounting medium (Vector Laboratories) and analysed
under a Zeiss LSM 700 confocal laser microscope (Carl
Zeiss, Madrid, Spain). To avoid overlapping, control prep-
arations were previously single stained for one marker,
and their fluorescence was evaluated with the three differ-
ent lasers used for final image acquisition. Band-pass fil-
ters were set up to avoid cross-talk between channels, and
sequential acquisition was performed during experiments
to excite fluorochromes one at a time.
Real-time RT-PCR analysis
Total RNA from ENS culture was extracted using the
RNeasy Mini Kit (QIAGEN, Las Matas, Spain), quanti-
fied by optical densitometry and assessed for integrity by
on-chip gel electrophoresis with the Experion™ System
(Bio-Rad Laboratories, el Prat de Llobregat, Spain). Then,
100 ng of RNA were retro-transcribed by using the
Transcriptor First-strand cDNA Synthesis Kit (Roche
Applied Science, Mannheim, Germany) for reverse-
transcriptase polymerase chain reaction (RT-PCR). Primer
sequences listed in Table 1 were designed to span introns
using the Universal ProbeLibrary Assay design Center
(https://lifescience.roche.com/webapp/wcs/stores/servlet/
CategoryDisplay?tab=Assay+Design+Center&identifier=-
Universal+Probe+Library&langId=-1), and checked for
specificity through BLAST search. PCR amplifications
were performed using the LC480 SYBR Green I Master-
mix (Roche Applied Science) according to manufacturer’s
protocol, and run on a LightCycler 480 II instrument
(Roche Applied Science). Absence of coamplification
products was assured by generating a final melting curve
for each reaction and by loading PCR products on a de-
naturing 2 % agarose gel, stained with SYBR safe (Life
Technologies) and visualized under UV transillumination.
Specificity of the primers was also determined by sequen-
cing these amplification products. Messenger RNA
(mRNA) level of expression of the genes of interest was
corrected to that of the S6 housekeeping gene and calcu-
lated by the ΔΔCt method.
In order to compare mRNA expression levels of the
receptors in basal conditions, absolute mRNA levels
were estimated by determining the difference between
the cycle threshold (Ct) of the target receptor and the
Ct of the housekeeping gene, as described elsewhere
[21, 24]. According to their ΔCt to the S6 gene, genes
were classified as high-expressed (ΔCt less than 5 cycles),
intermediate-expressed (ΔCt from 5 to 15 cycles), low or
Table 1 List of primers used for real-time RT-PCR analysis
Genes Sense primer Antisense primer Reference
rS6 CCAAGCTTATTCAGCGTCTTGTTACTCC CCCTCGAGTCCTTCATTCTCTTGGC NM_017160
rTLR2 CAGATGGCCAGAGGACTCA AATGGCCTTCCCTTGAGAG ENSRNOT00000013025.3
rTLR4 GGATGATGCCTCTCTTGCAT TGATCCATGCATTGGTAGGTAA NM_019178.1
rTLR9 TCCGTGACAATCACCTCTCTT GGTCCAGGTCTCGCAGATT NM_198131.1
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rare-expressed (ΔCt superior to 15 cycles) and undetect-
able (ΔCt superior to 40 cycles).
Western blot
ENS cultures were harvested in RIPA lysis buffer
(Millipore, Madrid, Spain) containing 2 mM sodium
orthovanadate, phosphatase inhibitor cocktail 3 (Sigma)
and a tablet of Complete™ protease inhibitors cocktail
(Roche Applied Science). Protein samples (30 μg) were
separated on a 10 % acrylamide gel containing 0.1 %
sodium dodecyl sulfate and transferred to a nitrocellu-
lose membrane with the iBlot™ Dry Blotting System (Life
Technologies). Membranes were blocked for 1 h at room
temperature with 5 % non-fat dry milk in Tris-buffered
saline (100 mM NaCl, 10 mM Tris, pH 7.5) with 0.1 %
Tween 20 (TBST), and incubated overnight at 4 °C with
primary antibodies in a 5 % BSA solution in TBST.
Bound antibodies were detected with HRP-conjugated
anti-rabbit or anti-mouse antibodies, and visualized by
enhanced chemiluminescent detection (ECL advance,
GE Healthcare). Membranes were stripped for 15 min in
Reblot buffer (Millipore), followed by extensive washing
in TBST before reblocking with 5 % non-fat dry milk in
TBST and reprobing for β-actin determination. Bands
were imaged in a LAS-3000 Imager (Fujifilm, Tokyo,
Japan) and quantified with Multigauge 3.0 software
(Fujifilm). To allow comparison between different mem-
branes, the density of the bands was referred to that of
untreated controls and normalized to the amount of
β-actin in the same sample.
TNF-α, IL-6 and MCP-1 ELISA
Culture supernatants were centrifuged, aliquoted and
frozen, and further assayed with the corresponding
BD OptEIA™ ELISA Sets (BD), following manufacturer’s
recommended assay procedures. Final cytokine or che-
mokine values were related to the total protein amount
of the sample, which was determined by using the BCA
protein assay kit (Pierce, Rockford, USA).
Migration assays
Twenty-four hours after stimulation of ENS primary
culture with MAMPs, conditioned supernatants were
centrifuged, placed into 24-well plates and left to equili-
brate for an hour with the transwell insert. Then, 105
RAW 264.7 macrophages were seeded in the upper
chamber of the 8-μm-pore transwell inserts, and allowed
to migrate for 4 h at 37 °C and 5 % CO2. After fixation
in 4 % paraformaldehyde, cells on the upper surface of
the transwell membrane were removed by rubbing with
a sterile cotton swab, and cells on the lower surface were
stained with DAPI. The average number of migrating
cells was determined by counting eight fields per
membrane at ×100 under a Carl Zeiss Axioskop 40 FL
epifluorescence microscope equipped with a Zeiss
AxioCam MRm camera (Carl Zeiss, Germany). Each
experiment was performed in duplicate.
Statistical analysis
Results are presented as mean values ± S.E.M. of at least
three independent experiments. All data were compared
using one-way or two-way ANOVA, followed by Tukey’s
post hoc test (unless otherwise stated). Where stated,
randomised block design analysis was performed to
minimise the variability due to differences between
individual culture responses. Data analysis and plot were
performed with GraphPad Prism 5.0 software (GraphPad
Software Inc., La Jolla, USA). Randomised block design
analyses were performed with Minitab 15 Statistical
Software (Minitab Inc., Pennsylvania, USA). A P value
<0.05 was considered to be significant.
Results
Enteric neurons express TLR2/4/9 in adult rat colon
Expression of TLR2/4/9 in whole-mount preparations
from adult rat colon was assessed by immunofluo-
rescence. Prominent immunoreactivity for the three
receptors was found in neurons from both SMP and
LMMP (Fig. 1), as demonstrated by colocalisation
with the neuronal markers Hu C/D or β-tubulin III.
However, distribution patterns were different for each
receptor. TLR2 staining was found in all neurons of
the SMP and the LMMP (Fig. 1, upper panels), whereas
TLR4 was only observed in discrete neuronal somas and
fibres (Fig. 1, middle panels, and Additional file 1). TLR9
reactivity was found in neurons and interganglionic
bundles, fully colocalising with the β-tubulin III marker
(Fig. 1, lower panels).
Since expression of TLR2 and 4 has previously been
described in EGCs [18, 19, 21], we additionally performed
colocalisation studies of the three receptors with the
enteroglial marker glial fibrillary acidic protein (GFAP).
Our results demonstrate minor localisation of the TLRs
studied in EGCs in the SMP (Additional file 2, left
panels). In the same vein, TLR4 and 9 showed minor
colocalisation with GFAP+ cells in the LMMP (Additional
file 2, right middle and lower panels). Conversely, TLR2
immunoreactivity was observed in some enteroglial
processes in the LMMP (Additional file 3), indicating that
this receptor is expressed in both neurons and EGCs.
TLR2/4/9 show similar expression patterns in rat
embryonic ENS culture
To determine whether rat embryonic ENS cultures
might be a good in vitro model to study the immune
functions of TLRs, we characterised their expression in
such set-up. The three receptors were found in ENS
cultures, displaying similar expression levels (Fig. 2a, b).
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Distribution of such receptors was circumscribed to
neuronal structures, either somas or axons. TLR2 was
found in all neurons (Fig. 2c, upper panels), whereas TLR4
was seen in most but not all somas, as well as in discrete
fibres (Fig. 2c, middle panels). TLR9 positive staining colo-
calised with β-tubulin III+ structures, including neuronal
somas (arrows) and nerve bundles (Fig. 2c, lower panels).
Microbial motifs induce TLR-mediated activation of the
NF-kB signalling pathway
Recognition of MAMPs through TLRs leads to activation
of different signalling cascades, including the NF-kB
pathway. Phosphorylation of the inhibitor of kB (IkB)-α
protein is necessary to target it for ubiquitination and
release NF-kB subunits, which are then able to translocate
to the nucleus [14]. Therefore, p-IkBα was used as an
indicator of TLR-induced activation of ENS cultures.
The three TLRs described were functional, as the li-
gands Pam2CSK4 (TLR2/6), LPS (TLR4) and ODN 1826
(TLR9) caused a time-dependent increase in phosphoryl-
ation of this protein (Fig. 3a, b). Furthermore, the cODN
1826, which does not bear the CG motifs, did not induce
NF-kB activation, demonstrating the selectivity of the
TLR9 ligand. Pre-incubation of ENS cultures with
15 μM Bay 11-7082 abrogated LPS-induced activation,
confirming the specific involvement of the NF-kB path-
way (Fig. 3a).
Activation kinetics observed for all MAMPs were simi-
lar, lasting from 1 to 48 h and peaking at 4–8 h (Fig. 3b).
However, activation intensity was ligand-specific, LPS
being the most potent inducer (LPS0.1 = 386.6 ± 61.8,
Pam2CSK4100 = 328.3 ± 29.14 and ODN 18261 = 110 ±
15.98 AUxhour; Additional file 4A-E).
Neuronal activation was determined through immu-
nofluorescent localisation of the NF-kB p65 subunit.
Unstimulated ENS culture showed cytoplasmic staining
for p65 in neurons and other undetermined cell types
(Fig. 3c, upper panels). However, 1 h after LPS stimu-
lation, p65 reactivity was preferentially seen in nuclear
localisation, colocalising with DAPI. Interestingly, some
of the TLR4-activated cells were HuC/D+ neurons (Fig. 3c,
lower panels), indicating that TLRs expressed in these
cells signal through the NF-kB pathway.
LPS stimulation induces a pro-inflammatory
microenvironment in ENS culture through the
NF-kB signalling cascade
Tumour necrosis factor (TNF)-α and interleukin (IL)-6
are secreted in rat embryonic ENS culture in response
to LPS [7]. In addition, IL-8 is also released in vitro by
LPS-stimulated jejunum biopsies [25]. Therefore, we
Fig. 1 TLR2/4/9 are expressed in enteric neurons of adult rat colon tissue. TLR localisation in whole-mount preparations of the SMP and the
LMMP. B-tubulin III was used instead of HuC/D as neuronal marker for colocalisation with TLR9 due to antibody detection incompatibilities.
Scale bars: 25 μm
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assessed the production of TNF-α, IL-6 and the mono-
cyte chemoattractant protein (MCP)-1 upon TLR2/4/9
ligand challenge, as well as the involvement of the NF-
kB pathway in these responses.
LPS addition to embryonic ENS culture elicited a
marked increase in all inflammatory mediators analysed
24 h after stimulation (Fig. 4a–c). In contrast, the TLR2/6
ligand Pam2CSK4 induced a slight, though not significant,
increase in TNF-α and MCP-1, whereas ODN 1826 was
not able to induce secretion of such molecules (Fig. 4a–c).
These results suggest that Gram-negative signalling in-
duces pro-inflammatory responses in embryonic ENS cul-
ture, while Gram-positive structures and bacterial DNA
do not, despite their ability to activate the NF-kB pathway.
Inhibition of the NF-kB pathway by Bay 11-7082 signi-
ficantly decreased the production of all studied media-
tors, but did not completely abrogate it (Fig. 4a–c). This
observation points out that other signalling pathways, such
Fig. 2 Embryonic ENS culture neurons express TLR2/4/9. a Agarose gel showing specific products of real-time PCR for the assayed genes in ENS
culture (PC); water was used as a no-template control (H2O) and rat colon cDNA as positive control (+C). b TLR relative expression in ENS culture in
basal conditions (n = 8). c Localisation of TLR in ENS culture ganglia. B-tubulin III was used instead of HuC/D as neuronal marker for colocalisation
with TLR9 due to antibody detection incompatibilities. White arrows point to neuronal somas. Scale bars: 25 μm
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as the mitogen-activated protein kinases (MAPK) cascade
[7], might also be involved in responses to these MAMPs.
TNF-α expression after LPS challenge has been de-
scribed in embryonic ENS neurons [7]. Since TLR4
staining in ENS cultures was found circumscribed to
neurons, we sought to determine whether TLR4+ cells
were responsible for the production of IL-6 and MCP-1
24 h after LPS challenge. Colocalisation studies revealed
that TLR4-expressing neurons produced IL-6 (Fig. 4d,
upper panels) and MCP-1 (Fig. 4d, lower panels).
However, macrophages did also show immunoreactivity to
IL-6 (Fig. 4d, upper panels, white arrows, and Additional
file 5) and MCP-1 antibodies (Additional file 6, white
arrows), pointing out that resident immunocytes are also
involved in responses to MAMPs in these cultures. Never-
theless, neurons were the only IL-6-producing cells that
stained positive for TLR4 (Additional file 7), suggesting
they act as primary sensors of LPS in these cultures.
TLR2 is up-regulated upon stimulation with TLR2/4/9 ligands
We next aimed to evaluate whether stimulation with one
particular MAMP might have cross-regulatory effects on
the expression of other TLRs, as has been previously
described [26, 27]. Quantitative PCR assays of ENS culture
showed consistent TLR2 up-regulation after an 8-h expo-
sure to the tested MAMPs (TLR2Pam2CSK4 = 18.78 ± 3.02,
TLR2LPS = 40.78 ± 7.84 and TLR2ODN 1826 = 8.29 ± 2 vs.
TLR2Ctrl = 1.23 ± 0.33 folds; Fig. 5a–c). Moreover, a slight
Fig. 3 MAMP stimulation induces activation of the NF-kB pathway in embryonic ENS culture. a Rat embryonic ENS culture was incubated for
8 h with the indicated MAMPs or the IkB phosphorylation inhibitor Bay 11-7082, and cell protein extraction and Western blot were performed
to determine phosphorylated IkB (P-IkBα). B-actin was used as a loading control. b Time-course densitometric quantification of P-IkBα bands
corrected to β-actin and related to basal activation levels; representative bands are shown in Additional file 4. Statistical analysis was performed
independently for each ligand, using one-way ANOVA followed by Dunnett’s test (n = 4 for each ligand and time point; *P < 0.05, **P < 0.01 and
***P < 0.001). c Representative micrographs showing NF-kB p65 subunit localisation in basal conditions (Ctrl) or 1 h after LPS challenge (LPS).
White arrows point to neuronal nuclei displaying p65 positive staining. Scale bars: 25 μm
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increase in TLR4 (TLR4LPS = 1.78 ± 0.28 vs. TLR4Ctrl =
1.06 ± 0.13 folds; Fig. 5b) and TLR9 expression (TLR9LPS
= 2.13 ± 0.53 vs. TLR9Ctrl = 1.1 ± 0.17 folds; Fig. 5b) was
observed after LPS challenge. Finally, ODN 1826 stimu-
lation did also up-regulate TLR9 expression (TLR9ODN
1826 = 2.28 ± 0.43 vs. TLR9Ctrl = 1.1 ± 0.17 folds; Fig. 5c).
Neutralisation of TLR2 modulates TLR4-mediated
production of inflammatory mediators
Consistent overexpression of TLR2 after MAMP chal-
lenge prompted us to study the involvement of this
receptor in LPS-elicited pro-inflammatory responses.
Pre-incubation with a TLR2-neutralising antibody
significantly decreased the release of TNF-α, IL-6 and
MCP-1 (Fig. 6a–c). These results point out that TLR2
shapes TLR4-driven responses to its ligand LPS,
increasing their final effect.
TLR4/9 synergise amplifying the pro-inflammatory
responses elicited by LPS
Given that the described alterations in TLR expression
might influence subsequent responses to LPS, we studied
the production cytokines and chemokines after combined
stimulation with the selected MAMPs.
Since TLR2 is strongly up-regulated after LPS expo-
sure, we expected that costimulation with Pam2CSK4
Fig. 4 ENS culture releases cytokines and chemokines in response to LPS. Rat embryonic ENS culture was stimulated for 24 h and culture
supernatants were collected and centrifuged prior to measuring cytokine and chemokine secretion. a TNF-α (n = 4–8; LPS vs. control and Bay
11-7082 + LPS, ***P < 0.001; Bay 11-7082 + LPS vs. control, ***P < 0.001). b IL-6 (n = 4–8; LPS vs. control and Bay 11-7082 + LPS, ***P < 0.001).
c MCP-1 (n = 4–8; LPS vs. control, ***P < 0.001; LPS vs. Bay 11-7082 + LPS, **P < 0.01). d Distribution studies show IL-6 and MCP-1 colocalisation
with TLR4+ neurons. White arrows show TLR4- IL-6-producing cells. Scale bars: 25 μm
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would increase cytokine and chemokine production.
However, addition of this ligand to LPS-challenged
ENS culture did not induce a higher mediator release
(Fig. 7a–c). Nevertheless, the inhibitory effects of Bay
11-7082 in production of IL-6 and MCP-1 were reverted
by this combined treatment (Fig. 7b, c), suggesting that
Pam2CSK4 + LPS incubation might involve activation of
signalling pathways other than NF-kB.
On the other hand, simultaneous addition of TLR4 and
TLR9 ligands (LPS and ODN 1826) caused a synergistic
Fig. 5 TLR activation in ENS culture is associated to TLR2 up-regulation.
TLR mRNA levels were assessed in rat ENS culture stimulated for 8 h with
the indicated MAMPs. a Pam2CSK4 (n= 5–10; TLR2 ligand vs. control,
***P< 0.001). b LPS (n= 5–10; TLR2 ligand vs. control, ***P< 0.001; TLR4
and TLR9 ligand vs. control, *P< 0.05). c ODN 1826 (n= 5–10; TLR2 ligand
vs. control, **P< 0.01; TLR9 ligand vs. control, *P< 0.05)
Fig. 6 TLR2 blockade reduces ENS culture responses to LPS.
Embryonic ENS culture was pre-incubated for 1 h with 10 μg/mL
of TLR2 neutralising antibody before an LPS challenge for 24
additional hours. a TNF-α (n = 3; LPS vs. αTLR2 + LPS, ***P < 0.001).
b IL-6 (n = 3; LPS vs. αTLR2 + LPS, ***P < 0.001). c MCP-1 (n = 3;
LPS vs. αTLR2 + LPS, *P < 0.05)
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increase in production of TNF-α and IL-6 in embryonic
ENS cultures (Fig. 7a, b; Table 2), and reduced the inhibi-
tory effects of Bay 11-7082 in MCP-1 production (Fig. 7c).
TLR2/4 and TLR4/9 interact enhancing chemoattraction
of a macrophage cell line
The release of MCP-1 regulates migration and infiltra-
tion of different cell types, especially monocytes/macro-
phages [28]. In addition, other chemokines might be
secreted in ENS culture upon stimulation with MAMPs
[29]. Therefore, we finally aimed to study whether the
supernatants of challenged ENS primary cultures could
induce the recruitment of immune cells.
MAMP-enriched DMEM culture medium did not
induce RAW 264.7 cell migration to the lower compart-
ment of the transwell inserts (data not shown). Similarly,
conditioned medium from non-stimulated ENS culture
did not increase migration when compared to DMEM
culture medium (data not shown). However, conditioned
medium obtained from LPS-stimulated ENS culture
showed a tendency to increase migration to the lower
chamber (59 % increase, P = 0.08; Fig. 8). This chemo-
tactic effect was further enhanced to a 107 and 112 %
increase by media conditioned by a combination of
Pam2CSK4 or ODN 1826 with LPS, respectively (P <
0.001 for both, Fig. 8). Taken together, these data suggest
that MAMPs themselves are not chemoattractant, but
LPS alone or in combination with other TLR ligands
elicits secretion of chemotactic substances by enteric
neurons and resident immunocytes, promoting migra-
tion of RAW 264.7 macrophages.
Discussion
Since their initial characterisation in human in the late
90s [13], TLRs have been widely described in several
tissues and cells, including central and peripheral ner-
vous systems [15, 30]. In recent years, the study of their
role in the ENS has gained attention; however, there are
still only a few works addressing their participation in the
immune response to microbes. In this study, we report
the expression and functionality of TLR2/4/9 in em-
bryonic ENS primary cultures, emphasising in their inter-
actions in terms of cytokine and chemokine production.
Our results indicate that enteric neurons respond to
MAMPs through secretion of inflammatory mediators,
integrating their signals to trigger a tailored response to
each challenge. Indeed, activation of TLR2 or TLR9 upon
LPS stimulation enhanced macrophage chemoattraction,
Fig. 7 TLR4/9 combined stimulation elicits synergic pro-inflammatory responses in ENS culture. Embryonic ENS cultures were incubated with the specified
combinations of MAMPs for 24 h. Randomised block design analysis followed by Tukey’s post hoc test was applied to minimise statistical differences due
to intrinsic culture responsiveness. a TNF-α (n= 4–9; ODN 1826 + LPS vs. LPS, ***P< 0.001; ODN 1826 + LPS vs. Bay 11-7082 + ODN 1826 + LPS, **P< 0.01).
b IL-6 (n= 4–9; ODN 1826 + LPS vs. LPS, ***P< 0.001; ODN 1826 + LPS vs. Bay 11-7082 + ODN 1826 + LPS, *P< 0.05). c MCP-1 (n= 4–9; LPS vs.
Bay 11-7082 + LPS, ***P< 0.001)
Table 2 Comparison between expected additive effects and measured effects of TLR ligand interactions in embryonic ENS culture
Cytokine TLR ligand combination Expected additive effect (%) Measured effect (%) N P
TNF-α Pam2CSK4 + LPS 53.9 ± 8.5 52.1 ± 7.8 5 0.744
ODN 1826 + LPS 51.9 ± 8.5 100 ± 20.4 5 0.02
IL-6 Pam2CSK4 + LPS 43.7 ± 5.7 45 ± 8.5 5 0.729
ODN 1826 + LPS 42.3 ± 5.9 100 ± 24.8 5 0.048
MCP-1 Pam2CSK4 + LPS 91.5 ± 3.6 85.2 ± 5.3 5 0.102
ODN 1826 + LPS 88.2 ± 4.3 100 ± 5.4 5 0.02
The mean production of TNF-α, IL-6 or MCP-1 elicited by ODN 1826 + LPS was considered as 100 % effect. The expected additive effect of the combination of
two ligands was calculated according to the model of functional interaction, represented by the equation E(ODN+LPS)expected = E(ODN)measured + E(LPS)measured –
E(ODN)measured * E(LPS)measured. Statistical comparisons were performed by means of randomised block design analysis to minimise the random effects due to
intrinsic culture responsiveness
Burgueño et al. Journal of Neuroinflammation  (2016) 13:187 Page 10 of 15
while potentiating different pro-inflammatory responses.
Taken together, these findings suggest that TLRs confer
the ENS the ability to discriminate microbial signals and
expand inflammation by promoting particular pro-
inflammatory microenvironments and interacting with
resident immunocytes to chemoattract immune cells.
These facts further support the idea that the ENS is an
immunologically active tissue.
Expression of TLRs within the ENS has been previously
assessed by other groups in full-thickness tissue sections
of the small intestine [18, 25]. In this regard, colocalisation
studies in SMP and LMMP whole-mounts from adult rat
colon offer an improved perspective to discern immuno-
reactive cell populations. Our findings in these tissues
confirm previous data about TLR2 expression, which had
been described in both HuC/D+ and GFAP+ cells [19].
Conversely, we could only observe TLR4 staining in some
subsets of enteric neurons [20, 25], even though expres-
sion in EGCs has been already reported [18, 21]. In this
regard, our results agree with parallel studies in central
nervous system cultures pointing out that neurons have
more prominent TLR4 expression than astrocytes [29].
Finally, the TLR9 expression patterns we report here
match with previous work that localise this receptor in
neuronal somas and β-tubulin III+ microtubules from
dorsal root ganglia cultures [31] and various brain sections
[32]. Interestingly, TLR distribution in embryonic ENS
primary cultures was very similar to that of adult tissues,
which might indicate that few modifications affect their
localisation during development. Indeed, minor TLR2 and
TLR4 expression variations have been observed in the
mouse developing brain, whereas TLR9 increases in adult-
hood [32].
Functional TLRs activate the NF-kB pathway in several
cell types, including neurons [33] and EGCs [21]. This
transcription factor has been shown to convey signals
from lipopeptides, LPS and class B CpG ODNs, leading
to production of cytokines and chemokines [13, 14, 34].
Our results indicate that NF-kB is also involved in ENS-
mediated recognition of MAMPs, but additionally suggest
that other signalling cascades may participate in cytokine
and chemokine production. Indeed, inhibition with Bay
11-7082 resulted in significant decrease in TNF-α, IL-6
and MCP-1 release, but not complete abrogation. There-
fore, it is likely that other pathways, such as the MAPK
and the 5-adenosine monophosphate-activated protein
kinase, are responsible for the observed mediator produc-
tion after NF-kB blockade, as they have been previously
Fig. 8 Stimulated ENS culture conditioned media induce chemoattraction of RAW 264.7 macrophages. RAW 264.7 macrophages were seeded
in the upper chamber of 8-μm-pore transwell inserts and left to migrate for 4 h towards lower chambers filled with stimulated ENS culture
conditioned media. Representative micrographs of the evaluated fields in the lower chamber of a transwell insert mounted upon unstimulated
(Ctrl), LPS-stimulated (LPS) or ODN 1826 + LPS-stimulated (ODN 1826 + LPS) ENS culture medium. Scale bars: 200 μm. Number of migrating cells
per field (n = 4, with two replicates for experiment; LPS vs. unstimulated ENS culture supernatant, #P = 0.08; Pam2CSK4 + LPS and ODN 1826 +
LPS vs. unstimulated ENS culture supernatant, ***P < 0.001). Randomised block design analysis was performed to minimise the variability in
migration due to RAW 264.7 passage, followed by Tukey’s post hoc test
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shown to play important roles in production of TNF-α in
embryonic ENS culture [7] and central nervous system
neurons [29].
Release of cytokines and other immunomodulatory
molecules is a common feature following TLR recognition
of MAMPs [13]. However, a number of adaptions have
developed in the gastrointestinal tract to prevent TLR-
driven immune responses to commensal microbes [35].
Some of these adaptions might also occur in the ENS, as
we observed no significant pro-inflammatory or chemo-
attractive responses in embryonic ENS culture upon
Pam2CSK4 or ODN 1826 stimulation, despite the fact
that they induced NF-kB activation. Similar observations
have been reported in human EGCs, in which translo-
cation into the nucleus of the NF-kB p50 subunit takes
place after exposure to enteropathogenic bacteria, but not
to probiotic strains [21]. These findings might underlie
selective mechanisms to signal microbe presence while
minimising responses to those non-pathogenic.
We have reported an active participation of resident
macrophages in IL-6 and MCP-1 production, which
poses an important limitation to the use of these em-
bryonic ENS cultures for immunologic research pur-
poses. Indeed, the neuronal or macrophage origin of the
released cytokines could not be quantified, making it
difficult to define the actual contribution of each cell type
to the inflammatory microenvironment and chemoattrac-
tive effects. We propose a major role for enteric neurons
because (1) expression of TLR2/4/9 was preferentially
seen in these cells; (2) TNF-α expression, which has been
localised by our collaborators in enteric neurons follow-
ing LPS exposure [7], was altered upon TLR2/4 and
TLR4/9 interactions; (3) MCP-1 reactivity following LPS
stimulation accumulated majorly in neurons and (4)
TLR2 up-regulation upon LPS challenge occurred in
neurons [7]. Even though the involvement of resident
immunocytes may be important, embryonic macrophages
display important phenotypic differences with adult mac-
rophages, such as no major histocompatibility complex
(MHC) class II expression or poor cytokine production
[36, 37]. Similarly, embryonic EGCs did not release IL-6
upon MAMP challenge, which is in contrast with pre-
vious observations in adult cells [8, 21].
Consistent up-regulation of TLR2 following MAMP or
cytokine stimulation has been described in astrocytes,
neurons and other cell types [7, 24, 38, 39]. Induction of
TLR2 mRNA is dependent on reactive oxygen species
[39] and ultimately on NF-kB, which has different bind-
ing sites on the TLR2 promoter region [40]. Overex-
pression of this receptor is necessary to reach maximal
NF-kB activation after MAMP recognition [38], possibly
through signalling the formation of lipoproteins bearing
lipid oxidation end-products [41, 42]. Our experiments
using a TLR2-blocking antibody agree with these
explanations, showing that in our setup, TLR2 induction
is crucial to obtain maximal TNF-α, IL-6 and MCP-1
production following LPS stimulation. Furthermore, in-
creased chemoattraction after combined challenge of
TLR2/4 suggests that these receptors may interact in ways
other than those we determined to enhance the release of
cytokines or chemokines. These additional interactions
might implicate activation of additional signalling path-
ways, since we report reduced responsiveness to NF-kB
inhibitors in ENS-mediated release of IL-6 and MCP-1
after Pam2CSK4 + LPS stimulation.
In addition to TLR2/4 cross-responsiveness pheno-
mena [43, 44], other TLR interactions after combined
MAMP challenge have been documented [23, 45, 46].
Here, we demonstrate strong synergic responses in TNF-α
release after costimulation with TLR4/9 ligands. Further-
more, IL-6 production and chemoattraction of macro-
phages by supernatants from ODN 1826 + LPS-treated
embryonic cultures were also significantly enhanced,
suggesting that additional chemokines might be induced
after combined TLR4/9 challenge. Similar interactions
between both receptors have been characterised in micro-
glia, dendritic cells and bone marrow-derived macrophages
[23, 46, 47]. The molecular mechanisms which may
account for such effects are TLR9 up-regulation following
LPS stimulation, as we and others have described [46], as
well as enhanced signalling and duration through alterna-
tive pathways, such as the MAPK [47]. From a functional
point of view, the ability to integrate different stimuli from
the same microorganism contributes to discrimination
of commensals and pathogens, inducing robust pro-
inflammatory responses against the latter [48]. Recogni-
tion of Gram-negative motifs from both membrane (LPS)
and nucleus (CpG DNA) is hence integrated in a synergic
way, triggering strong pro-inflammatory responses and
promoting chemoattraction of immune cells. In contrast,
detection of Gram-positive and Gram-negative molecular
patterns (Pam2CSK4 and LPS) lead to similar chemotactic
responses but to a not so harsh pro-inflammatory envi-
ronment, which might result into a milder priming of the
subsequent effector response.
Different studies have addressed the involvement of
central and peripheral nervous system neurons in defence
against pathogens. These studies demonstrate that LPS
stimulation activates NF-kB and MAPK pathways in these
cells to induce production of cytokines like TNF-α and IL-
6, and chemokines such as RANTES and KC [29, 33].
Participation of enteric neurons in inflammation has been
also demonstrated. Transgenic mice displaying increased
and reduced numbers of neurons develop, respectively,
more and less severe experimental colitis than wild-type
littermates, suggesting that neurons play pro-inflammatory
roles [4]. Furthermore, different signalling pathways are
activated in these cells upon IL-1β or LPS challenge [7, 49],
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leading to production of IL-8 and TNF-α [6, 7]. Our find-
ings show that enteric neurons express TLR2/4/9,signal
through the NF-kB pathway and release IL-6 and MCP-1
in response to LPS challenge. These observations add
further evidence to the pro-inflammatory roles of neurons,
and set them as active players in neuroimmune interactions
in the gastrointestinal tract, participating in microbial
recognition and priming subsequent immune responses.
Conclusions
Our data suggest that the ENS is capable of recognising
and discriminating between different microbial challenges,
triggering robust or moderate inflammatory responses
depending on the combination of TLR stimulated, as well
as interacting with resident immunocytes to induce
chemoattraction of macrophages. Given the fact that
neurons are the main TLR-expressing cells in the enteric
plexuses and are activated upon MAMP challenge to
produce TNF-α, IL-6 and MCP-1, they arise as important
players in enhancement of neuroimmune interactions.
Additional files
Additional file 1: TLR2/4/9 antibodies specifically stain ENS structures in
WT mouse tissues. Tissue from WT, TLR2−/− and TLR4−/− mice was stained
with TLR2/4 antibodies to test their staining specificity. In micrographs from
WT mice, positive neurons were distinguished by strong immunoreactivity
(white arrows) when compared to negative ones (open arrows). Knockout
mice tissues displayed background immunoreactivity in neurons and
unspecific secondary antibody precipitates. Pictures in this Add. File were
taken in a Leica TCS SP5 microscope. Scale bars: 25 μm. The unconjugated
TLR9 antibody (clone 26C593.2) raised in mouse could not be used to
detect this receptor in mouse whole mounts, due to secondary antibody
cross-reactivity with neurons, muscle fibres and supportive cells in the
submucosa (TLR9 MOM). Conversely, the biotinylated form of this antibody
displayed strong staining in the LMMP (black arrows) that was not observed
in TLR9−/− preparations (Biot TLR9). Antigen retrieval was achieved by
boiling sections in 10 mM sodium citrate pH 6, followed by quenching of
peroxidases and avidin/biotin blocking. After primary antibody incubation
overnight at 4 °C, sections were washed, incubated with ABC-HRP kit and
developed with DAB (both from Vector Laboratories). Haematoxylin was
used to counterstain tissues. Scale bars: 20 μm. (TIF 12107 kb)
Additional file 2: TLR2/4/9 display minor colocalisation with GFAP in
adult rat plexuses. TLR colocalisation with the EGC marker GFAP in
whole-mount preparations of the SMP and the LMMP. White arrows
point to enteroglial processes colocalising with TLR expression.
Scale bars: 25 μm. (TIF 2537 kb)
Additional file 3: TLR2 colocalises with glial structures in adult LMMP.
Different insets from LMMP micrographs in Fig. 1 and Additional file 2
were generated to demonstrate colocalisation between TLR2 and
GFAP-expressing EGCs (arrows). (TIF 2932 kb)
Additional file 4: Time-course activation of NF-kB and dose-dependence.
Time-course activation after stimulation of ENS cultures with (A) 100 ng/mL
Pam2CSK4, (B) 100 ng/mL LPS, (C) 1 μM ODN 1826 or (D) 1 μM control
ODN 1826. (E) Quantification of the overall NF-kB activation after treatment
with different doses of the indicated MAMPs. Densitometric measurements
for each experiment were represented as time-course curves by means of
the GraphPad Prism 5.0, and the area under the curve was calculated for
each replicate. The resulting values were used to compare the NF-kB
inducing strength of each TLR ligand (n = 4; *P < 0.05, **P < 0.01 and
***P < 0.001, one-way ANOVA followed by Dunnett’s post hoc test).
Statistics were performed independently for each ligand.
(TIF 13694 kb)
Additional file 5: Resident immunocytes, but not EGCs, express IL-6. ENS
cultures were costained for S100β (EGC marker), IBA-1 (macrophage marker)
and IL-6 after 24 h stimulation with LPS. Scale bars: 25 μm. (TIF 1791 kb)
Additional file 6: MCP-1 staining is more prominent in TLR4-expressing
cells. ENS cultures were stimulated for 24 h with LPS and costained for
MCP-1 and TLR4. Although cells displayed different staining intensities
for TLR4, positive populations showed increased MCP-1 intensity
(open arrows). MCP-1 was also observed in TLR4-negative cells,
presumably macrophages, but the staining intensity was lower
(white arrows). Scale bars: 25 μm. (TIF 857 kb)
Additional file 7: Neurons are the only TLR4-expressing cells in ENS
cultures. ENS cultures were stimulated for 24 h with LPS and costained
for Hu C/D and TLR4. IL-6 antibody was also added to visualise
macrophages (arrows). TLR4 was located exclusively in Hu C/D
positive cells. Scale bars: 25 μm. (TIF 1806 kb)
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